Azenta SEC filings: 8-K
Filter: All · 8-K · 10-Q · 10-K · Form 4
Entry into a material definitive agreement · Regulation FD disclosure · Other events
AI summary, unreviewedAzenta Announces Elegen License and SynPlexity Acquisition, With $32 Million to $71 Million Aggregate Capital Deployment
Costs of exit or disposal activities · Material impairments · Financial statements and exhibits
AI summary, unreviewedAzenta, Inc. Approves Restructuring Plan With $11.0 Million to $13.0 Million in Charges and $11.0 Million Annualized Savings
Departure/appointment of directors or officers · Financial statements and exhibits
Regulation FD disclosure · Other events · Financial statements and exhibits
Departure/appointment of directors or officers · Regulation FD disclosure
Departure/appointment of directors or officers · Financial statements and exhibits
Results of operations and financial condition · Financial statements and exhibits